Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 6/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10923763 | 0.79 | MTNR1A (0.44) | MTNR1AMTNR1BALDH1A1NQO2TP53 | |
| SCHEMBL10834075 | 0.75 | TAAR1 (0.43) | — | |
| SCHEMBL10923169 | 0.75 | MTNR1A (0.41) | MTNR1AMTNR1BALDH1A1NQO2TP53 | |
| SCHEMBL10919751 | 0.74 | CYP1A2 (0.40) | CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL9688747 | 0.74 | ALDH1A1 (0.51) | MTNR1AMTNR1BALDH1A1NQO2TP53 | |
| SCHEMBL7272227 | 0.73 | ALDH1A1 (0.55) | MTNR1AMTNR1BALDH1A1TP53HSD17B10 | |
| SCHEMBL5076870 | 0.72 | MTNR1A (0.68) | MTNR1AMTNR1BALDH1A1 | |
| SCHEMBL27229064 | 0.72 | MTNR1A (0.65) | MTNR1AMTNR1BNQO2HSD17B10 | |
| SCHEMBL10923168 | 0.72 | MTNR1A (0.39) | MTNR1AMTNR1BALDH1A1NQO2CYP1A2 | |
| SCHEMBL9786035 | 0.71 | SLC2A1 (0.47) | MTNR1AMTNR1BALDH1A1NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0189473-B1 | NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-05-27 | — | — | EP | disclosed |
| US-4958026-A | HYPOTENSIVE AGENTS | SCHERING AKTIENGESLLSCHAFT (DE) | 1990-09-18 | — | — | US | disclosed |
| EP-0189473-A1 | NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS. | SCHERING AG (DE) | 1986-08-06 | — | — | EP | disclosed |
| EP-0046666-B1 | 2(3H)-INDOLONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | SMITHKLINE BECKMAN CORPORATION (US) | 1986-04-23 | — | — | EP | disclosed |
| WO-1986001204-A1 | NEW DOPAMINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE AS MEDICINAL PRODUCTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-02-27 | — | — | WO | disclosed |
| US-4414224-A | 4-AMINO OR SUBSTITUTED AMINO-7-HYDROXY-2-(3H)-INDOLONES | SMITHKLINE BECKMAN CORPORATION (US) | 1983-11-08 | — | — | US | disclosed |
| EP-0046666-A1 | 2(3H)-indolones, process for their preparation and compositions containing them | SMITHKLINE BECKMAN CORPORATION (US) | 1982-03-03 | — | — | EP | disclosed |
| US-4314944-A | CARDIOVASCULAR DISORDERS, HYPOTENSIVE AGENTS | SMITHKLINE CORPORATION (US) | 1982-02-09 | — | — | US | disclosed |